Biopharmx Corporatio (BPMX) 3.4500 $BPMX BioPharmX

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biopharmx Corporatio (BPMX) 3.4500 $BPMX

BioPharmX Corporation Announces Violet(TM) Iodine is Now Available at The Vitamin Shoppe®
PR Newswire - Mon Apr 20, 7:00AM CDT
BioPharmX Corporation (OTCQB: BPMX), makers of Violet(TM) iodine, the new, once-daily, non-prescription iodine supplement for the relief of premenstrual breast discomfort*, today announced that new Violet iodine is now available at The Vitamin Shoppe®.

BioPharmX Corporation Files Registration Statement For Proposed Public Offering
PR Newswire - Thu Apr 09, 4:37PM CDT
BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of proprietary drug delivery products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed public offering of its common stock. The number of shares to be offered by BioPharmX and the price range for the offering have not yet been determined.

BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors
PR Newswire - Mon Mar 30, 8:30AM CDT
BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Stephen Morlock, a seasoned financial executive and retail industry veteran, to its board of directors. Mr. Morlock's background will assist the company as it continues to expand its national roll-out of Violet iodine, the new, once-daily, non-prescription pill for relief of premenstrual breast discomfort, and he will serve as an independent board member on BioPharmX Corporation's audit, compensation and nominating and corporate governance committees.

BioPharmX Corporation Completes Pre-IND Meeting With U.S. FDA To Review Its Topical Acne Solution
PR Newswire - Wed Mar 18, 7:00AM CDT
BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that its planned pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) was held on March 11, 2015, as scheduled. The pre-IND meeting focused on the company's topical antibiotic acne compound currently under development and the company's proposed strategy for advancing its acne program and plans for conducting safety and toxicology studies, along with human clinical trials.

BioPharmX Announces Violet(TM) Iodine Now Available at Leading National Retailer
PR Newswire - Tue Mar 10, 7:00AM CDT
BioPharmX Corporation (OTCQB: BPMX), makers of Violet(TM) iodine, the new, once-daily, non-prescription pill for the relief of premenstrual breast discomfort, today announced the first-of-its-kind product has added a major U.S. drugstore chain to its retail partners. The daily supplement is available now and will be offered exclusively in the feminine care aisle.

BioPharmX names Michael Hubbard as chair of audit committee
M2 - Fri Jan 30, 2:10AM CST
Biotechnology company BioPharmX (OTCBB:BPMX) disclosed on Wednesday the addition of Michael Hubbard as a new independent member of its board of directors, increasing the board's total number of members to four.

BioPharmX Corporation Appoints Michael Hubbard To Its Board Of Directors
PR Newswire - Wed Jan 28, 10:30AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Michael Hubbard as a new independent member of its board of directors. Hubbard, a seasoned financial executive with a career in public accounting and auditing, will also lead the company's audit committee. Hubbard's appointment brings the board's total number of members to four.

BioPharmX Corporation Granted Pre-IND Meeting With U.S. FDA To Review Its Topical Acne Solution
PR Newswire - Mon Jan 12, 9:00AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has been granted a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration to discuss the company's topical antibiotic acne compound currently under development. The meeting, currently scheduled for March 2015, is expected to focus on the company's proposed strategy for advancing its acne program and plans for conducting safety and toxicology studies, along with human clinical trials.

BioPharmX Corporation To Present At OneMed Forum SF 2015 Conference
PR Newswire - Thu Jan 08, 9:00AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that Jim Pekarsky, chief executive officer and co-founder of BioPharmX, will present at the OneMed Forum SF 2015 Conference on Monday, January 12 at 3:00 p.m. PST at the Marriott Marquis in San Francisco.

UPM Pharmaceuticals to Manufacture BioPharmX's First Commercially Available Product
PR Newswire - Wed Dec 10, 8:00AM CST
UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with BioPharmX, Inc. (OTCQB: BPMX) to commercially manufacture solid dose iodine supplement tablets for the consumer products sector. The tablets will be manufactured at UPM's 475,000 square-foot manufacturing facility in Bristol, Tennessee, under a commercial supply agreement. Terms of the agreement were not disclosed.

BioPharmX unveils Violet iodine for relief of premenstrual breast discomfort and symptoms associated with Fibrocystic Breast Condition
M2 - Wed Dec 10, 6:27AM CST
Biotechnology company BioPharmX (OTCBB:BPMX) disclosed on Tuesday the market launch of its new, once-daily pill for relief of premenstrual breast discomfort, Violet iodine.

Introducing Violet(TM) Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort*
PR Newswire - Tue Dec 09, 8:37AM CST
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of VioletTM iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*

BioPharmX Corporation Announces Submission Of Pre-IND Meeting Request To The U.S. FDA For Its Topical Acne Solution
PR Newswire - Tue Dec 02, 6:30AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration (FDA) for the company's topical antibiotic acne compound currently under development. The company plans to follow up by submitting a briefing package on a later date in support of a pre-IND meeting to review the company's proposed strategy and plan for conducting safety and toxicology studies and human clinical trials required for approval of its acne product.

BiopharmX Announces Breast Health Medical Advisory Board
PR Newswire - Mon Nov 17, 7:00AM CST
BioPharmX Corporation (OTCQB: BPMX) today announced the formation of a Breast Health Medical Advisory Board (MAB) composed of highly respected physicians selected to provide a depth and range of experience in breast health. Members will serve as a strategic resource to BioPharmX as it develops products that address unmet breast health needs. Specifically, the advisory board will provide clinical trial and protocol design advice and guidance regarding emerging breast health trends and new product opportunities.

BioPharmX Corporation Announces Appointment Of Ping Wang Of Korea Investment Partners To Board Of Directors
PR Newswire - Mon Nov 10, 7:10AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced the appointment of Mr. Ping Wang, Principal of Korea Investment Partners, to the company's board of directors. Mr. Wang's appointment follows Korea Investment Partners' investment in BioPharmX as part of its Series A private placement, which was also announced today.

BioPharmX Corporation Secures Up To $12 Million In Private Placement
PR Newswire - Mon Nov 10, 7:00AM CST
BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, announced that the Company has secured up to $12 million in a Series A private placement (Series A). The $12 million in total funding secured includes convertible notes previously converted to common shares, as well as the Series A private placement, which was completed in a series of closings that occurred between May 2014 and November 2014. The total amount includes $2 million in funding subject to the company achieving certain milestones. The proceeds are being used to advance the Company's pipeline of products in the fields of women's health and dermatology and to fund the near-term launch and commercialization of the Company's women's health product. The Series A private placement was led by Korea Investment Partners (KIP), which is now represented on BioPharmX's board of directors, and complemented by a combination of accredited institutional investors and high-net worth private individuals.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 70

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 72

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 18

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 304

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Boat Market Forecast Puts Services in the Driver’s Seat

Updated Category News Views 51

A jet ski is not exactly a sober economic indicator, yet the water is telling a useful story. MarketsandMarkets projects the global recreational boat market will rise from $31.38 billion in 2026 to $48.06 billion in 2033, a 6.3% compound annual growth rate. That is respectable growth for a costly discretionary category that got knocked around by softer purchasing activity...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 61

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 91

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 116

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 60

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 248

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading

Top 5 Most Recently Viewed Articles

SAIHEAT Unveils Innovations at SC24 for Sustainable Data Centers

Updated Category News Views 237

SAIHEAT Showcases Groundbreaking Solutions at SC24 SAIHEAT Limited (formerly SAI.TECH Global Corporation) (NASDAQ: SAIH, SAITW) is excited to announce its inaugural appearance at the Supercomputing 2024 (SC24) Conference. This pivotal event takes place from November 18-21 in Atlanta, providing SAIHEAT a platform to present innovative technologies designed for the future...

Continue Reading
NetEase: A Comprehensive SWOT Analysis Amidst Market Changes

Updated Category News Views 879

NetEase (NASDAQ: NTES), Inc. faced significant hurdles back in 2024 as it battled through a maturing gaming landscape. Known for its dominance in China's online gaming sector, the company encountered delays in game releases that shook investor confidence and triggered a reevaluation of future projections by analysts. While its mobile offerings continued to pull weight,...

Continue Reading
MIMARU Eases Travel in Tokyo with New Support Hub

Updated Category News Views 44

Tourists and Tokyo: MIMARU Bridges the Gap Imagine you're trekking through the bustling streets of Tokyo with your family, and out of nowhere, the heavens open and send down a torrent. Your phone’s dead, you’re drenched to the bone, and the kids are whining in sync about needing to find a restroom. Now, wouldn't it be nice to have a friendly place nearby offering a...

Continue Reading
Exploring the Rapid Growth of the Cloud Logistics Sector

Updated Category News Views 248

Understanding the Cloud Logistics Landscape The Cloud Logistics Market is on an impressive growth trajectory, projected to reach a staggering USD 76.42 billion by the end of the forecast period. This remarkable estimation follows a significant rise from its previous valuation of USD 27.69 billion in 2024, indicating a compound annual growth rate (CAGR) of 13.53% from 2025...

Continue Reading
Institute of Culinary Education Honors 2025 Graduates at Ceremony

Updated Category News Views 615

Institute of Culinary Education Celebrates Its Graduates The Institute of Culinary Education (ICE) is set to honor its latest culinary graduates with an inspiring commencement ceremony at its Los Angeles campus. As ICE marks this important milestone in its history, it is also a moment to celebrate the institution's 50th anniversary, where culinary dreams turn into...

Continue Reading